RIV.V - Canopy Rivers Inc.

TSXV - TSXV Delayed Price. Currency in CAD
2.9800
-0.0700 (-2.30%)
As of 10:27AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close3.0500
Open3.0200
Bid2.9800 x 0
Ask2.9900 x 0
Day's Range2.9700 - 3.0600
52 Week Range0.1550 - 6.3300
Volume46,259
Avg. Volume381,607
Market Cap166.711M
Beta (3Y Monthly)N/A
PE Ratio (TTM)149.00
EPS (TTM)0.0200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.79
  • Could This Canopy Growth (TSX:WEED) Spin-Off Be a Great Buy?
    The Motley Fool2 days ago

    Could This Canopy Growth (TSX:WEED) Spin-Off Be a Great Buy?

    Canopy Rivers Inc. (TSXV:RIV) has an interesting business strategy and could benefit substantially from the growing marijuana market. But is it a buy right now?

  • Cannabis venture capital firm Canopy Rivers reports $1.8-million Q4 loss
    The Canadian Press3 days ago

    Cannabis venture capital firm Canopy Rivers reports $1.8-million Q4 loss

    Canopy Rivers Inc., the venture capital arm of cannabis company Canopy Growth Corp., swung to a loss in its latest quarter as its operating expenses soared. The Toronto-based firm reported Tuesday a loss of $1.8 million in the three months ended March 31 compared with a profit of nearly $14.6 million in the same quarter last year. Canopy Rivers said as positive global sentiment towards pot rises and Canada legalizes edibles, topicals and extracts, there is growth potential for the industry and ancillary businesses which do not touch the plant.

  • Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update
    CNW Group3 days ago

    Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update

    TORONTO, July 16, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSXV:RIV.V - News) (OTC:CNPOF - News) today released its financial results for the three and twelve months ended March 31, 2019. The Company's audited consolidated financial statements for the twelve months ended March 31, 2019, and its full Management's Discussion and Analysis (the "MD&A") for the three and twelve months ended March 31, 2019, are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/financials. "It was a year full of milestones and significant achievements for Canopy Rivers," said Narbe Alexandrian, President and Chief Executive Officer of Canopy Rivers.

  • Market Exclusive9 days ago

    Cannabis Stock News Daily Roundup July 10

    Zenabis Global (OTCMKTS:ZBISF) has submitted its site evidence package to Health Canada for the first phase of its facility in Langley. Called Zenabis Langley, the facility’s first 50,000 sq. ft. flower room is substantially complete, while work on the remaining five flower rooms and additional support space, totaling 380,000 sq. ft., is set to complete […]The post Cannabis Stock News Daily Roundup July 10 appeared first on Market Exclusive.

  • Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta
    CNW Group10 days ago

    Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta

    TORONTO , July 9, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company, YSS Corp. (" YSS ") ...

  • Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada
    CNW Group11 days ago

    Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada

    TORONTO, July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (TSXV:JWCA.V - News) (OTCQX:JWCAF - News), has received approval of a licence amendment from Health Canada. This licence amendment allows for the sale of formulated cannabis oil from JWC's pilot facility in Kitchener, Ontario.

  • Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada
    CNW Group11 days ago

    Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company TerrAscend Corp. (" TerrAscend ...

  • Market Exclusive14 days ago

    Cannabis Stock News Daily Roundup July 5

    Cannabis Stock News The Cannabis Council of Canada (C3) applauded the Government of Ontario for their decision to expand adult use retail cannabis licenses. With national cannabis supply levels improving, C3 believes that the continued and sustained expansion of Ontario's retail network will be a key factor in replacing the illicit cannabis market with a legal […]The post Cannabis Stock News Daily Roundup July 5 appeared first on Market Exclusive.

  • CNW Group16 days ago

    Canopy Rivers Announces Change to Board of Directors

    TORONTO , July 3, 2019 /CNW/ - Further to Canopy Growth Corporation's press release today, Bruce Linton has also stepped down as Chairman and Director of Canopy Rivers Inc. (the "Company" or ...

  • CNW Grouplast month

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

    TORONTO, June 19, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019. The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on June 20, 2019.

  • Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal
    CNW Grouplast month

    Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal

    TORONTO and SAN DIEGO, June 19, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers", the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) and ZeaKal, Inc. ("ZeaKal") are pleased to announce an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration (link) with Corteva Agriscience (NYSE:CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont.

  • CNW Grouplast month

    Canopy Rivers announces grant of options

    TORONTO , June 13, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) has granted incentive stock options under the Company's stock option ...

  • Market Exclusive2 months ago

    Agripharm Wins Approval for Outdoor Cultivation License

    Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company Agripharm Corp. received its outdoor cultivation license from Health Canada. Agripharm is co-owned by SLANG (CNSX: SLNG), Canopy Growth (NYSE: CGC) and Green House Holdings North America and received a strategic investment from Canopy Rivers. Canopy Rivers provided the capital to finance the build-out […]The post Agripharm Wins Approval for Outdoor Cultivation License appeared first on Market Exclusive.

  • Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available
    CNW Group2 months ago

    Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available

    TORONTO, May 28, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News), (OTC:CNPOF - News) will be hosting its analyst and investor day from 1:00 p.m. to 5:00 p.m. ET today, May 28. The webcast will be available on Canopy Rivers' website immediately prior to the event at www.canopyrivers.com/investors/events. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition.  This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.

  • CNW Group2 months ago

    Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada

    Final 190,000 sq. ft. Greenhouse Licensed. Total of 700,000 sq. ft. of Production and Processing Infrastructure Now Fully Licensed MIRABEL, QC , May 28, 2019 /CNW/ - Les Serres Vert Cannabis Inc. ("Vert ...

  • Canopy Rivers Hosts analyst and Investor Day
    CNW Group2 months ago

    Canopy Rivers Hosts analyst and Investor Day

    TORONTO , May 23, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) today announced that it will host an analyst and investor day on Tuesday, ...

  • Canopy Rivers Appoints Narbé Alexandrian as Chief Executive Officer
    CNW Group2 months ago

    Canopy Rivers Appoints Narbé Alexandrian as Chief Executive Officer

    TORONTO, May 22, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSXV:RIV.V - News) today announced the promotion of former OMERS venture capitalist and Canopy Rivers President, Mr. Narbé Alexandrian, to Chief Executive Officer of the Company, effective immediately. Bruce Linton has transitioned from his role as acting CEO and will continue to provide oversight, deal flow, strategic insight, and opportunities for collaboration and further strategic alignment with Canopy Growth in conjunction with his ongoing role as Chairman of the Canopy Rivers Board of Directors.

  • Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence
    CNW Group2 months ago

    Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence

    TORONTO, May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada.

  • Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry
    CNW Group2 months ago

    Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry

    TORONTO and PALMERSTON NORTH, New Zealand, May 15, 2019 /CNW/ - BioLumic Ltd. ("BioLumic"), creators of a sustainable ultraviolet (UV) crop yield enhancement system, and Canopy Rivers Inc. ("Canopy Rivers") (TSXV:RIV.V - News), (OTC:CNPOF - News) today announced a strategic investment from Canopy Rivers. BioLumic extended the Finistere Ventures-led Series A financing round to include Canopy Rivers' strategic investment of US$1.5 million, closing the oversubscribed round at US$6.7 million. This marks Canopy Rivers' first investment in agri-technologies, specifically focused on the promising fields of plant physiology and UV photobiology.

  • Baystreet2 months ago

    Stocks in play: Canopy Rivers Inc.

    Says its 49%-owned joint venture PharmHouse Inc. has signed an offtake agreement with Canopy Growth ...

  • Canopy Growth announces offtake agreement with PharmHouse
    CNW Group2 months ago

    Canopy Growth announces offtake agreement with PharmHouse

    SMITHS FALLS, ON, May 9, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED.TO - News) (NYSE:CGC - News) is pleased to announce today that has signed an offtake agreement with PharmHouse Inc. ("PharmHouse"), a 49 per cent-owned joint venture of Canopy Rivers Inc. (TSXV:RIV.V - News) (OTC:CNOPOF). Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years. Boasting 1.3 million square feet of greenhouse grow space, and leveraging the resources of Canopy Growth, Canopy Rivers and its joint venture partner have worked diligently since October 2018 to prepare the facility for licensing.  PharmHouse will leverage Canopy Growth's genetics – selected and supplied by the Company – and flower will be returned to the Company to be sold under Canopy Growth's diverse brands and banners.  Under the terms of the new offtake agreement, PharmHouse is committed to producing GMP-certified, high quality cannabis flower within 18 months of its cultivation license and the flower must comply with the Company's high standards for cannabis quality.

  • Canopy Rivers Announces Significant Supply Agreement Between PharmHouse and Canopy Growth
    CNW Group2 months ago

    Canopy Rivers Announces Significant Supply Agreement Between PharmHouse and Canopy Growth

    TORONTO, May 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that its portfolio company PharmHouse Inc. ("PharmHouse") has entered into a second offtake agreement (the "Agreement") with Canopy Growth Corporation ("Canopy Growth") (TSX:WEED.TO - News) (NYSE:CGC - News) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. The Agreement commits an additional 20% of PharmHouse's flowering space to Canopy Growth for the next three years, in addition to the 10% that was originally committed in May 2018.

  • Meet the Canopy Growth (TSX:WEED) of Finance Stocks
    The Motley Fool2 months ago

    Meet the Canopy Growth (TSX:WEED) of Finance Stocks

    Most people are aware that Canopy Growth Corp (TSX:RIV)(NYSE:RIV) is a leader in the cannabis space. What most don't know is that it has a strong partnership in finance.